Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ORTHO PLANNED RENOVA TIE-IN WITH OUTSIDE COSMETIC LINE IN 1990 -- TESTIMONY FROM RILEY TRIAL; FORMER DIVISION HEAD ACQUITTED OF FOUR COUNTS IN CASE

Executive Summary

Ortho was planning in 1990 to market its photoaging product Renova with a line of cosmetic products supplied by an outside company, according to the recent testimony of former Ortho Dermatologics Division President Lester Riley.

You may also be interested in...



TAP Execs Acquitted Of Conspiracy Charges Related To Marketing Practices

The acquittal of eight current and former TAP employees on conspiracy charges suggests that the perception of shifting standards for marketing compliance will make it difficult for prosecutors to translate corporate settlements into convictions of individual executives

TAP Execs Acquitted Of Conspiracy Charges Related To Marketing Practices

The acquittal of eight current and former TAP employees on conspiracy charges suggests that the perception of shifting standards for marketing compliance will make it difficult for prosecutors to translate corporate settlements into convictions of individual executives

Schering-Plough Faces Criminal Case; Off-Label Promotion May Be One Count

A criminal investigation of Schering-Plough's marketing practices includes off-label promotion, the company disclosed May 30

Latest Headlines
See All
UsernamePublicRestriction

Register

PS027462

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel